| Literature DB >> 24970787 |
Chahra Chbili1, Fatma B'chir2, Maha Ben Fredj3, Bochra-Nourhène Saguem3, Sana Ben Amor4, Sofiene Ben Ammou4, Saad Saguem5.
Abstract
Glutathione-S-transferases enzymes are involved in the detoxification of several endogenous and exogenous substances. In this present study, we evaluated the effects of two glutathione-S-transferase polymorphisms, (GSTM1 and GSTT1) on epilepsy risk susceptibility in a Tunisian population. These polymorphisms were analyzed in 229 healthy subjects and 98 patients with epilepsy, using a polymerase chain reaction (PCR). Odds ratio (ORs) was used for analyzing results. The study results demonstrated that individuals with the GSTM1 null genotype were at an increased risk of developing epilepsy [OR=3.80, 95% confidence interval (CI) (2.15-4.78)], whereas no significant effects were observed between individuals with GSTT1 null genotype and epilepsy risk [OR=1.15, 95% CI (0.62-2.12)]. These genotyping finding revealed that the absence of GSTM1 activity could be contributor factor for the development of epilepsy disease.Entities:
Keywords: Epilepsy-genetic polymorphisms; Glutathione-S-transferase M1; Glutathione-S-transferase T1
Mesh:
Substances:
Year: 2014 PMID: 24970787 DOI: 10.1016/j.eplepsyres.2014.05.009
Source DB: PubMed Journal: Epilepsy Res ISSN: 0920-1211 Impact factor: 3.045